One of the hardest issues for newly diagnosed prostate cancer patients to deal with has long been the differences in opinion between physicians about appropriate first-line treatment (and the relevant information they are offered) — most especially for patients with localized disease. The advent of multidisciplinary prostate cancer clinics (which dates back to the mid-1990s, […]![]()
